Novo Nordisk A/S ADR Stock
€60.80
Your prediction

sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Not a member yet? Sign up for free!
Financial data and news for Novo Nordisk
sharewise wants to provide you with the best news and tools for Novo Nordisk, so we directly link to the best financial data sources.
Financials
News

Novoordisk A/S Stock: Q4 Profits Soar Past Expectations
Danish pharmaceutical giant Novoordisk A/S exceeded market expectations with an impressive 37 percent surge in fourth-quarter profits, driving its stock price up by 4.5 percent. The company's

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Novo Nordisk A/S (“Novo Nordisk” or the “Company”) (NYSE: NVO) and reminds investors of the